PURPOSE: The purpose of this study was to evaluate a set of widely used nuclear medicine imaging agents as possible methods to study the early effects of systemic inflammation on the living brain in a mouse model of sepsis-associated encephalopathy (SAE). The lipopolysaccharide (LPS)-induced murine systemic inflammation model was selected as a model of SAE. PROCEDURES: C57BL/6 mice were used. A multimodal imaging protocol was carried out on each animal 4 h following the intravenous administration of LPS using the following tracers: [99mTc][2,2-dimethyl-3-[(3E)-3-oxidoiminobutan-2-yl]azanidylpropyl]-[(3E)-3-hydroxyiminobutan-2-yl]azanide ([99mTc]HMPAO) and ethyl-7-[125I]iodo-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate ([125I]iomazenil) to measure brain perfusion and neuronal damage, respectively; 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) to measure cerebral glucose uptake. We assessed microglia activity on another group of mice using 2-[6-chloro-2-(4-[125I]iodophenyl)-imidazo[1,2-a]pyridin-3-yl]-N-ethyl-N-methyl-acetamide ([125I]CLINME). Radiotracer uptakes were measured in different brain regions and correlated. Microglia activity was also assessed using immunohistochemistry. Brain glutathione levels were measured to investigate oxidative stress. RESULTS: Significantly reduced perfusion values and significantly enhanced [18F]FDG and [125I]CLINME uptake was measured in the LPS-treated group. Following perfusion compensation, enhanced [125I]iomazenil uptake was measured in the LPS-treated group's hippocampus and cerebellum. In this group, both [18F]FDG and [125I]iomazenil uptake showed highly negative correlation to perfusion measured with ([99mTc]HMPAO uptake in all brain regions. No significant differences were detected in brain glutathione levels between the groups. The CD45 and P2Y12 double-labeling immunohistochemistry showed widespread microglia activation in the LPS-treated group. CONCLUSIONS: Our results suggest that [125I]CLINME and [99mTc]HMPAO SPECT can be used to detect microglia activation and brain hypoperfusion, respectively, in the early phase (4 h post injection) of systemic inflammation. We suspect that the enhancement of [18F]FDG and [125I]iomazenil uptake in the LPS-treated group does not necessarily reflect neural hypermetabolism and the lack of neuronal damage. They are most likely caused by processes emerging during neuroinflammation, e.g., microglia activation and/or immune cell infiltration.

Biological Nanochemistry Research Group Institute of Materials and Environmental Chemistry Research Centre for Natural Sciences Hungarian Academy of Sciences Budapest Hungary

CROmed Translational Research Centers Budapest H 1047 Hungary

Department of Biophysics and Radiation Biology Semmelweis Univ Budapest H 1094 Hungary

Helmholz Zentrum Dresden Rossendorf Radiopharmazie Radiopharmaceutische Biologie Dresden Germany

Laboratory of Neuroimmunology Institute of Experimental Medicine Budapest Hungary

Nuclear Physics Institute of the CAS CZ 250 68 Rez Czech Republic

Progressio Fine Chemical Engineering Ltd Székesfehérvár Hungary

Zobrazit více v PubMed

Chaudhry N, Duggal AK. Sepsis associated encephalopathy. Adv Med. 2014;2014:762320. doi: 10.1155/2014/762320. PubMed DOI PMC

Zampieri FG, Park M, Machado FS, Azevedo LC. Sepsis-associated encephalopathy: not just delirium. Clinics. 2011;66:1825–1831. doi: 10.1590/S1807-59322011001000024. PubMed DOI PMC

Ning Q, Liu Z, Wang X, Zhang R, Zhang J, Yang M, Sun H, Han F, Zhao W, Zhang X. Neurodegenerative changes and neuroapoptosis induced by systemic lipopolysaccharide administration are reversed by dexmedetomidine treatment in mice. Neurol Res. 2017;39:357–366. doi: 10.1080/01616412.2017.1281197. PubMed DOI

Laye S, Parnet P, Goujon E, Dantzer R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Brain Res Mol Brain Res. 1994;27:157–162. doi: 10.1016/0169-328X(94)90197-X. PubMed DOI

Gabellec MM, Griffais R, Fillion G, Haour F. Expression of interleukin 1 alpha, interleukin 1 beta and interleukin 1 receptor antagonist mRNA in mouse brain: regulation by bacterial lipopolysaccharide (LPS) treatment. Brain Res Mol Brain Res. 1995;31:122–130. doi: 10.1016/0169-328X(95)00042-Q. PubMed DOI

Pitossi F, del Rey A, Kabiersch A, Besedovsky H. Induction of cytokine transcripts in the central nervous system and pituitary following peripheral administration of endotoxin to mice. J Neurosci Res. 1997;48:287–298. doi: 10.1002/(SICI)1097-4547(19970515)48:4<287::AID-JNR1>3.0.CO;2-7. PubMed DOI

Ban E, Haour F, Lenstra R. Brain interleukin 1 gene expression induced by peripheral lipopolysaccharide administration. Cytokine. 1992;4:48–54. doi: 10.1016/1043-4666(92)90036-Q. PubMed DOI

Hoogland IC, Houbolt C, van Westerloo DJ, et al. Systemic inflammation and microglial activation: systematic review of animal experiments. J Neuroinflamm. 2015;12:114. doi: 10.1186/s12974-015-0332-6. PubMed DOI PMC

Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 2007;55:453–462. doi: 10.1002/glia.20467. PubMed DOI PMC

Ming Z, Wotton CA, Appleton RT, Ching JC, Loewen ME, Sawicki G, Bekar LK. Systemic lipopolysaccharide-mediated alteration of cortical neuromodulation involves increases in monoamine oxidase-A and acetylcholinesterase activity. J Neuroinflamm. 2015;12:37. doi: 10.1186/s12974-015-0259-y. PubMed DOI PMC

Abdel-Salam OM, Youness ER, Mohammed NA, et al. Citric acid effects on brain and liver oxidative stress in lipopolysaccharide-treated mice. J Med Food. 2014;17:588–598. doi: 10.1089/jmf.2013.0065. PubMed DOI PMC

Varatharaj A, Galea I. The blood-brain barrier in systemic inflammation. Brain Behav Immun. 2017;60:1–12. doi: 10.1016/j.bbi.2016.03.010. PubMed DOI

Zhou H, Andonegui G, Wong CH, Kubes P. Role of endothelial TLR4 for neutrophil recruitment into central nervous system microvessels in systemic inflammation. J Immunol. 2009;183:5244–5250. doi: 10.4049/jimmunol.0901309. PubMed DOI

Bohatschek M, Werner A, Raivich G. Systemic LPS injection leads to granulocyte influx into normal and injured brain: effects of ICAM-1 deficiency. Exp Neurol. 2001;172:137–152. doi: 10.1006/exnr.2001.7764. PubMed DOI

Sharshar T, Gray F, Lorin de la Grandmaison G, et al. Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet. 2003;362:1799–1805. doi: 10.1016/S0140-6736(03)14899-4. PubMed DOI

Mazeraud A, Pascal Q, Verdonk F, Heming N, Chrétien F, Sharshar T. Neuroanatomy and physiology of brain dysfunction in sepsis. Clin Chest Med. 2016;37:333–345. doi: 10.1016/j.ccm.2016.01.013. PubMed DOI

Burkhart CS, Siegemund M, Steiner LA. Cerebral perfusion in sepsis. Crit Care. 2010;14:215. doi: 10.1186/cc8856. PubMed DOI PMC

Bozza FA, D'Avila JC, Ritter C, et al. Bioenergetics, mitochondrial dysfunction, and oxidative stress in the pathophysiology of septic encephalopathy. Shock. 2013;39(Suppl 1):10–16. doi: 10.1097/SHK.0b013e31828fade1. PubMed DOI

Pulli B, Chen JW. Imaging neuroinflammation—from bench to bedside. J Clin Cell Immunol. 2014;5:226. PubMed PMC

Stubbs DJ, Yamamoto AK, Menon DK. Imaging in sepsis-associated encephalopathy—insights and opportunities. Nat Rev Neurol. 2013;9:551–561. doi: 10.1038/nrneurol.2013.177. PubMed DOI

Chang JM, Lee HJ, Goo JM, Lee HY, Lee JJ, Chung JK, Im JG. False positive and false negative FDG-PET scans in various thoracic diseases. Korean J Radiol. 2006;7:57–69. doi: 10.3348/kjr.2006.7.1.57. PubMed DOI PMC

Kapucu OL, Nobili F, Varrone A, Booij J, Vander Borght T, Någren K, Darcourt J, Tatsch K, van Laere KJ. EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2. Eur J Nucl Med Mol Imaging. 2009;36:2093–2102. doi: 10.1007/s00259-009-1266-y. PubMed DOI

Abiko K, Ikoma K, Shiga T, Katoh C, Hirata K, Kuge Y, Kobayashi K, Tamaki N. I-123 iomazenil single photon emission computed tomography for detecting loss of neuronal integrity in patients with traumatic brain injury. EJNMMI Res. 2017;7:28. doi: 10.1186/s13550-017-0276-1. PubMed DOI PMC

Saito H, Magota K, Zhao S, Kubo N, Kuge Y, Shichinohe H, Houkin K, Tamaki N, Kuroda S. 123I-iomazenil single photon emission computed tomography visualizes recovery of neuronal integrity by bone marrow stromal cell therapy in rat infarct brain. Stroke. 2013;44:2869–2874. doi: 10.1161/STROKEAHA.113.001612. PubMed DOI

Toyama H, Matsumura K, Nakashima H, Takeda K, Takeuchi A, Koga S, Yoshida T, Ichise M. Characterization of neuronal damage by iomazenil binding and cerebral blood flow in an ischemic rat model. Ann Nucl Med. 1998;12:267–273. doi: 10.1007/BF03164912. PubMed DOI

Hatazawa J, Shimosegawa E. Imaging neurochemistry of cerebrovascular disease with PET and SPECT. Q J Nucl Med. 1998;42:193–198. PubMed

Mattner F, Quinlivan M, Greguric I, et al. Radiosynthesis, in vivo biological evaluation, and imaging of brain lesions with [123I]-CLINME, a new SPECT tracer for the translocator protein. Dis Markers. 2015;2015:729698. doi: 10.1155/2015/729698. PubMed DOI PMC

Tai YF, Piccini P. Applications of positron emission tomography (PET) in neurology. J Neurol Neurosurg Psychiatry. 2004;75:669–676. doi: 10.1136/jnnp.2003.028175. PubMed DOI PMC

Kobayashi K, Yamanaka H, Fukuoka T, Dai Y, Obata K, Noguchi K. P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain. J Neurosci. 2008;28:2892–2902. doi: 10.1523/JNEUROSCI.5589-07.2008. PubMed DOI PMC

Swiatkowski P, Murugan M, Eyo UB, Wang Y, Rangaraju S, Oh SB, Wu LJ. Activation of microglial P2Y12 receptor is required for outward potassium currents in response to neuronal injury. Neuroscience. 2016;318:22–33. doi: 10.1016/j.neuroscience.2016.01.008. PubMed DOI PMC

Greter M, Lelios I, Croxford AL. Microglia versus myeloid cell nomenclature during brain inflammation. Front Immunol. 2015;6:249. doi: 10.3389/fimmu.2015.00249. PubMed DOI PMC

Denes A, Coutts G, Lenart N, et al. AIM2 and NLRC4 inflammasomes contribute with ASC to acute brain injury independently of NLRP3. Proc Natl Acad Sci U S A. 2015;112:4050–4055. doi: 10.1073/pnas.1419090112. PubMed DOI PMC

Szalay G, Martinecz B, Lenart N, et al. Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke. Nat Commun. 2016;7:11499. doi: 10.1038/ncomms11499. PubMed DOI PMC

Bonnini S, Corain L, Marozzi M, Salmaso L, et al. One- and two-sample location problems, tests for symmetry and tests on a single distribution. In: Balding DJ, et al., editors. Nonparametric hypothesis testing: rank and permutation methods with application in R. Chichester: John Wiley & Sons; 2014. pp. 1–37.

Schramm P, Klein KU, Falkenberg L, Berres M, Closhen D, Werhahn KJ, David M, Werner C, Engelhard K. Impaired cerebrovascular autoregulation in patients with severe sepsis and sepsis-associated delirium. Crit Care. 2012;16:R181. doi: 10.1186/cc11665. PubMed DOI PMC

Berg RMG, Plovsing RR, Bailey DM, Holstein-Rathlou NH, Møller K. The dynamic cerebral autoregulatory adaptive response to noradrenaline is attenuated during systemic inflammation in humans. Clin Exp Pharmacol Physiol. 2015;42:740–746. doi: 10.1111/1440-1681.12421. PubMed DOI

Taccone FS, Scolletta S, Franchi F, Donadello K, Oddo M. Brain perfusion in sepsis. Curr Vasc Pharmacol. 2013;11:170–186. PubMed

Wilson JX, Young GB. Progress in clinical neurosciences: sepsis-associated encephalopathy: evolving concepts. Can J Neurol Sci. 2003;30:98–105. doi: 10.1017/S031716710005335X. PubMed DOI

Semmler A, Hermann S, Mormann F, Weberpals M, Paxian SA, Okulla T, Schäfers M, Kummer MP, Klockgether T, Heneka MT. Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism. J Neuroinflammation. 2008;5:38. doi: 10.1186/1742-2094-5-38. PubMed DOI PMC

Byrnes KR, Wilson CM, Brabazon F, et al. FDG-PET imaging in mild traumatic brain injury: a critical review. Front Neuroenerg. 2014;5:13. doi: 10.3389/fnene.2013.00013. PubMed DOI PMC

Rosengarten B, Krekel D, Kuhnert S, Schulz R. Early neurovascular uncoupling in the brain during community acquired pneumonia. Crit Care. 2012;16:R64. doi: 10.1186/cc11310. PubMed DOI PMC

Rosengarten B, Hecht M, Auch D, Ghofrani HA, Schermuly RT, Grimminger F, Kaps M. Microcirculatory dysfunction in the brain precedes changes in evoked potentials in endotoxin-induced sepsis syndrome in rats. Cerebrovasc Dis. 2007;23:140–147. doi: 10.1159/000097051. PubMed DOI

Backes H, Walberer M, Ladwig A, Rueger MA, Neumaier B, Endepols H, Hoehn M, Fink GR, Schroeter M, Graf R. Glucose consumption of inflammatory cells masks metabolic deficits in the brain. NeuroImage. 2016;128:54–62. doi: 10.1016/j.neuroimage.2015.12.044. PubMed DOI PMC

Hong SY, Tobias G, Al-Jamal KT, et al. Filled and glycosylated carbon nanotubes for in vivo radioemitter localization and imaging. Nat Mater. 2010;9:485–490. doi: 10.1038/nmat2766. PubMed DOI

Jang B, Park S, Kang SH, Kim JK, Kim SK, Kim IH, Choi Y. Gold nanorods for target selective SPECT/CT imaging and photothermal therapy in vivo. Quant Imaging Med Surg. 2012;2:1–11. PubMed PMC

Mathe D, Horvath I, Szigeti K, et al. In vivo SPECT and ex vivo autoradiographic brain imaging of the novel selective CB1 receptor antagonist radioligand [125I]SD7015 in CB1 knock-out and wildtype mouse. Brain Res Bull. 2013;91:46–51. doi: 10.1016/j.brainresbull.2013.01.001. PubMed DOI PMC

Su N, Dang Y, Liang G, Liu G. Iodine-125-labeled cRGD-gold nanoparticles as tumor-targeted radiosensitizer and imaging agent. Nanoscale Res Lett. 2015;10:160. doi: 10.1186/s11671-015-0864-9. PubMed DOI PMC

Yu KO, Narayanan L, Mattie DR, Godfrey RJ, Todd PN, Sterner TR, Mahle DA, Lumpkin MH, Fisher JW. The pharmacokinetics of perchlorate and its effect on the hypothalamus-pituitary-thyroid axis in the male rat. Toxicol Appl Pharmacol. 2002;182:148–159. doi: 10.1006/taap.2002.9432. PubMed DOI

Tonacchera M, Pinchera A, Dimida A, Ferrarini E, Agretti P, Vitti P, Santini F, Crump K, Gibbs J. Relative potencies and additivity of perchlorate, thiocyanate, nitrate, and iodide on the inhibition of radioactive iodide uptake by the human sodium iodide symporter. Thyroid. 2004;14:1012–1019. doi: 10.1089/thy.2004.14.1012. PubMed DOI

Pandharipande PP, Girard TD, Ely EW. Long-term cognitive impairment after critical illness. N Engl J Med. 2014;370:185–186. PubMed

Muller V, Saur D, Klutmann S, et al. Experience with 123I-iomazenil SPECT in acute cerebral infarction. Nucl Med Commun. 2002;23:1191–1196. doi: 10.1097/00006231-200212000-00007. PubMed DOI

Nakagawara J, Kamiyama K, Takahashi M, Nakamura H. Cortical neuron loss in post-traumatic higher brain dysfunction using 123I-iomazenil SPECT. Acta Neurochir Suppl. 2013;118:245–250. PubMed

Rasmussen LS, Sperling B, Abildstrom HH, Moller JT. Neuron loss after coronary artery bypass detected by SPECT estimation of benzodiazepine receptors. Ann Thorac Surg. 2002;74:1576–1580. doi: 10.1016/S0003-4975(02)03955-3. PubMed DOI

Parente A, Vallez Garcia D, Shoji A, et al. Contribution of neuroinflammation to changes in [11C]flumazenil binding in the rat brain: evaluation of the inflamed pons as reference tissue. Nucl Med Biol. 2017;49:50–56. doi: 10.1016/j.nucmedbio.2017.03.001. PubMed DOI

Liu H, Leak RK, Hu X. Neurotransmitter receptors on microglia. Stroke Vasc Neurol. 2016;1:52–58. doi: 10.1136/svn-2016-000012. PubMed DOI PMC

Fraser DD, Mudrick-Donnon LA, MacVicar BA. Astrocytic GABA receptors. Glia. 1994;11:83–93. doi: 10.1002/glia.440110203. PubMed DOI

Lee M, Schwab C, McGeer PL. Astrocytes are GABAergic cells that modulate microglial activity. Glia. 2011;59:152–165. doi: 10.1002/glia.21087. PubMed DOI

Yoon BE, Woo J, Lee CJ. Astrocytes as GABA-ergic and GABA-ceptive cells. Neurochem Res. 2012;37:2474–2479. doi: 10.1007/s11064-012-0808-z. PubMed DOI

Barragan A, Weidner JM, Jin Z, Korpi ER, Birnir B. GABAergic signalling in the immune system. Acta Physiol. 2015;213:819–827. doi: 10.1111/apha.12467. PubMed DOI

Nigam R, El-Nour H, Amatya B, Nordlind K. GABA and GABA(A) receptor expression on immune cells in psoriasis: a pathophysiological role. Arch Dermatol Res. 2010;302:507–515. doi: 10.1007/s00403-010-1052-5. PubMed DOI

Kassiou M, Meikle SR, Banati RB. Ligands for peripheral benzodiazepine binding sites in glial cells. Brain Res Rev. 2005;48:207–210. doi: 10.1016/j.brainresrev.2004.12.010. PubMed DOI

Bahar FG, Ohura K, Ogihara T, Imai T. Species difference of esterase expression and hydrolase activity in plasma. J Pharm Sci. 2012;101:3979–3988. doi: 10.1002/jps.23258. PubMed DOI

Wilms H, Claasen J, Rohl C, et al. Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: evidence from activated microglial cells in vitro. Neurobiol Dis. 2003;14:417–424. doi: 10.1016/j.nbd.2003.07.002. PubMed DOI

Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, Price G, Wegner F, Giovannoni G, Miller DH, Perkin GD, Smith T, Hewson AK, Bydder G, Kreutzberg GW, Jones T, Cuzner ML, Myers R. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain. 2000;123:2321–2337. doi: 10.1093/brain/123.11.2321. PubMed DOI

Chen MK, Guilarte TR. Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. Pharmacol Ther. 2008;118:1–17. doi: 10.1016/j.pharmthera.2007.12.004. PubMed DOI PMC

Banati RB. Visualising microglial activation in vivo. Glia. 2002;40:206–217. doi: 10.1002/glia.10144. PubMed DOI

Hannestad J, Gallezot JD, Schafbauer T, Lim K, Kloczynski T, Morris ED, Carson RE, Ding YS, Cosgrove KP. Endotoxin-induced systemic inflammation activates microglia: [11C]PBR28 positron emission tomography in nonhuman primates. NeuroImage. 2012;63(1):232–239. doi: 10.1016/j.neuroimage.2012.06.055. PubMed DOI PMC

Sandiego CM, Gallezot JD, Pittman B, Nabulsi N, Lim K, Lin SF, Matuskey D, Lee JY, O’Connor KC, Huang Y, Carson RE, Hannestad J, Cosgrove KP. Imaging robust microglial activation after lipopolysaccharide administration in humans with PET. Proc Natl Acad Sci U S A. 2015;112:12468–12473. doi: 10.1073/pnas.1511003112. PubMed DOI PMC

Haynes SE, Hollopeter G, Yang G, Kurpius D, Dailey ME, Gan WB, Julius D. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci. 2006;9:1512–1519. doi: 10.1038/nn1805. PubMed DOI

Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, Koeglsperger T, Dake B, Wu PM, Doykan CE, Fanek Z, Liu LP, Chen Z, Rothstein JD, Ransohoff RM, Gygi SP, Antel JP, Weiner HL. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat Neurosci. 2014;17:131–143. doi: 10.1038/nn.3599. PubMed DOI PMC

Moore CS, Ase AR, Kinsara A, Rao VTS, Michell-Robinson M, Leong SY, Butovsky O, Ludwin SK, Séguéla P, Bar-Or A, Antel JP. P2Y12 expression and function in alternatively activated human microglia. Neurol Neuroimmunol Neuroinflamm. 2015;2:e80. doi: 10.1212/NXI.0000000000000080. PubMed DOI PMC

Trowbridge IS, Thomas ML. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu Rev Immunol. 1994;12:85–116. doi: 10.1146/annurev.iy.12.040194.000505. PubMed DOI

Cosenza-Nashat MA, Kim MO, Zhao ML, Suh HS, Lee SC. CD45 isoform expression in microglia and inflammatory cells in HIV-1 encephalitis. Brain Pathol. 2006;16:256–265. doi: 10.1111/j.1750-3639.2006.00027.x. PubMed DOI PMC

Akiyama H, Ikeda K, Katoh M, McGeer EG, McGeer PL. Expression of MRP14, 27E10, interferon-alpha and leukocyte common antigen by reactive microglia in postmortem human brain tissue. J Neuroimmunol. 1994;50:195–201. doi: 10.1016/0165-5728(94)90046-9. PubMed DOI

Melief J, Koning N, Schuurman KG, van de Garde MDB, Smolders J, Hoek RM, van Eijk M, Hamann J, Huitinga I. Phenotyping primary human microglia: tight regulation of LPS responsiveness. Glia. 2012;60:1506–1517. doi: 10.1002/glia.22370. PubMed DOI

Chen Z, Jalabi W, Shpargel KB, Farabaugh KT, Dutta R, Yin X, Kidd GJ, Bergmann CC, Stohlman SA, Trapp BD. Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4. J Neurosci. 2012;32:11706–11715. doi: 10.1523/JNEUROSCI.0730-12.2012. PubMed DOI PMC

Visualisation of in vivo protein synthesis during mycobacterial infection through [68Ga]Ga-DOTA-puromycin µPET/MRI